Drawing for TOXBAR

USPTO serial 99369694

TOXBAR

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
GLUECK, CHRISTOPHER N
Law office
TMO LAW OFFICE 112

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TOXBAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Mueller

John Mueller BakerHostetler312 Walnut StreetSuite 3200Cincinnati, OH 45202-4074

Goods and services

ClassDescriptionStatusFirst use
005Medical preparations in the nature of a hyaluronic acid based barrier substance injected between the prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; Medical preparations in the nature of a gel substance injected between the prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; Medical preparations in the nature of a gel barrier product used to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer.ACTIVE—
010Medical devices, namely, surgical implants made of synthetic materials in the nature of a hyaluronic acid based barrier substance injected between the prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; Medical devices, namely, surgical implants made of synthetic materials in the nature of a gel injected between the prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; Kits for use in medical and surgical procedures comprising applicators in the nature of injection needles and a hyaluronic acid based substance for medical use; surgical and medical apparatus and instruments for use in injecting a gel between an organ at risk and an organ with cancer creating a space between the two for protecting the organ at risk from radiation during radiotherapy treatment for the organ with cancer; Medical apparatus in the nature of a medical barrier device used to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 2, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 16, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 16, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jul 16, 2026CNSLSUSPENSION LETTER WRITTEN—
Jul 15, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 15, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 15, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 8, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 8, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 22, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2026DOCKASSIGNED TO EXAMINER—
Jan 21, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 2, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 2, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance